Acquisition of Volume Correctors, Solutions for Organ Preservation, Hemodialysis, Hemofiltration, and Other Sterile Solutions, under CPA 2025/1439

This tender focuses on the procurement of a range of critical medical solutions and supplies. The scope includes 'Volume Correctors' (Corretivos da volémia), which are likely intravenous fluids used to restore or maintain blood volume. Additionally, the tender covers 'Solutions for Organ Preservation', essential for transplant procedures and maintaining organ viability ex vivo. It also includes supplies for 'Hemodialysis' and 'Hemofiltration', vital treatments for patients with kidney failure. Finally, the procurement encompasses 'Other Sterile Solutions', indicating a broad requirement for aseptic solutions used in various medical and surgical contexts. This acquisition is being conducted under the Cooperative Purchasing Agreement (CPA) with reference 2025/1439. The objective is to ensure a consistent and reliable supply of these essential medical products, which are critical for patient care in hospital settings, intensive care units, and specialized treatment centers. The use of a CPA suggests a collaborative procurement effort aimed at achieving economies of scale and standardizing the acquisition of these vital medical consumables.

This is a supplies contract in the health and medical services, rural development and information and communication technology sectors, with a focus on Cooperatives, Hospitals and Medical Equipment. Located in Portugal, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 56,055.

Published through base_gov_pt, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.